Edition:
United Kingdom

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.59USD
19 Oct 2018
Change (% chg)

$0.02 (+0.78%)
Prev Close
$2.57
Open
$2.60
Day's High
$2.77
Day's Low
$2.59
Volume
7,492
Avg. Vol
16,761
52-wk High
$4.09
52-wk Low
$1.86

Chart for

About

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in... (more)

Overall

Beta: 1.24
Market Cap(Mil.): $55.71
Shares Outstanding(Mil.): 15.39
Dividend: --
Yield (%): --

Financials

  EVOK.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -0.89 -- --
ROI: -230.38 14.75 14.27
ROE: -428.40 16.24 15.99

BRIEF-Evoke Pharma Granted Gender Specific Patent For Gimoti In Mexico

* EVOKE GRANTED GENDER SPECIFIC PATENT FOR GIMOTI™ IN MEXICO Source text for Eikon: Further company coverage:

10 May 2018

Competitors

Earnings vs. Estimates